Specialty Copay Programs: When an Unstoppable Force Meets an Immovable Object

ACPE UAN #:  0233-0000-17-027-H04-P

Release DateMarch 29, 2017

Expiration Date:  March 29, 2020

Activity Type:    Knowledge-based

Contact Hours:  1.25

Activity Fee:  Member:  $15        Non-Member: $30

Target Audience: Pharmacists who practice in managed care settings.

Activity Overview

The prevalence of copay cards for high cost specialty pharmacy drugs continues to grow. These controversial programs place payers, specialty pharmacies and pharmaceutical manufacturers at odds. Higher copays, which used to deter patients from higher cost drugs, are now being o‑ set by these copay programs, leaving payers responsible for higher drug costs. As a result, payers are exploring new means of shifting costs to beneficiaries, while specialty pharmacies are trying to determine where their­ fiduciary responsibilities lie.  What is the outlook for copay programs? What are the strategies to manage access to these programs? What is the impact on actuarial and underwriting models? What about the impact for payer contracts and rebates? Where can payers, manufacturers and specialty pharmacies ­ and common ground? This session provides an overview of today’s landscape based on original research with key stakeholders and explores the future of these copay programs.

Learning Objectives:  

At the completion of this activity, participants should be able to:

1. Summarize the types of copay programs currently offered for specialty drugs and describe how these programs are likely to change in the future. 

2. Explain the impact copay cards have on actuarial models and underwriting and discuss what effect changes to copay programs would have on cost and utilization.

3. Outline management strategies used to address copay cards and detail the emerging tools and techniques available for guiding access to these programs. 

Schedule of Educational Activity

This activity consists of an audio recording, pre-test assessment questions (not required to pass or continue), post-test questions (required to pass with a score of 70% or higher) and a specific activity evaluation. 

CPE Requirements:   

Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at the AMCP Annual Meeting 2017. 

CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor.  Please allow 72 hours for processing and posting in your NABP account.

To receive credit for an online activity you must:

  • Review the full content of the activity.
  • Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
  • Complete a specific activity evaluation.

System Technical Requirements/Viewing Requirements: System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities you should have a basic comfort level using a computer and navigating web sites.  View the minimum technical and system requirements for continuing education online learning activities.

As an accredited provider, AMCP strictly adheres to the ACPE Standards for Commercial Support and other relevant guidelines and standards to ensure the independence of continuing pharmacy education (CPE) activities.  It is AMCP’s intent that all CPE activities be independent, objective, balanced, evidence-based and free of any commercial bias.

Moderator:

Renee Rizzo Fleming, RPh, MBA | President | PRN Managed Care Consulting Services, LLC | East Amherst, New York

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE UAN #0233-0000-17-027-H04-P 1.25 Contact Hours March 29, 2017 - March 29, 2020